Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine

Toxicology and Applied Pharmacology

Volumn 139, Issue 1, 1996, Pages 102-108

  Vaccari, A ^a   Saba, P L ^a   Ruiu, S ^a   Collu, M ^a   Devoto, P ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CATTLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG INTOXICATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; RAT;

ANIMALIA; BOS TAURUS;

EID: 0030200933     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0147     Document Type: Article

References (57)

1. Arbuthnott, G. W., Fairbrother, I. S., and Butcher, S. P. (1990). Dopamine release and metabolism in the rat striatum: An analysis by 'in vivo' brain microdialysis. Pharmacol. Ther. 48, 281-293.
2. Benloucif, S., Keegan, M. J., and Galloway, M. P. (1993). Serotonin-facilitated dopamine release in vivo: Pharmacological characterization. J. Pharmacol. Exp. Ther. 265, 373-377.
3. Benuck, M., and Reith, M. E. A. (1992). Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn-Schm. Arch. Pharmacol. 345, 666-672.
4. 3 receptors in rat striatum. J. Pharmacol. Exp. Ther. 251, 803-809.
5. Brooks, J. C., and Treml, S. (1983). Catecholamine secretion by chemically skinned cultured chromaffin cells. J. Neurochem. 40, 468-473.
6. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543, 354-357.
7. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
8. Chesselet, M.-F. (1984). Presynaptic regulation of neurotransmitter release in the brain: Fact and hypothesis. Neuroscience 12, 347-375.
9. Critchley, E. M. R. (1987). Neuropathies due to drugs. In Handbook of Clinical Neurology (P. J. Vinken, G. W. Bruyn, and H. L. Klawans, Eds.), pp. 293-314. Elsevier Science Publ., Amsterdam.
10. + uptake into synaptic dopamine vesicles: Possible involvement in MPTP toxicity. Br. J. Pharmacol. 109, 411-414.
11. Devoto, P., Collu, M., Muntoni, A. L., Pistis, M., Serra, G., Gessa, G. L., and Diana, M. (1995). Biochemical and electrophysiological effects of 7-OH-DPAT on the mesolimbic dopaminergic system. Synapse 20, 153-155.
12. Eldjarn, L. (1950). The metabolism of tetraethylthiuram disulphide (Antabuse, Aversan) in man, investigated by means of radioactive sulphur. Neurology 31, 730-735.
13. Ellenhorn, M. J., and Barceloux, D. G. (1988). Medical Toxicology, pp. 422-431. Elsevier, New York.
14. Eneanya, D. I., Bianchine, J. R., Duran, D. O., and Andresen, B. D. (1981). The actions and metabolic fate of disulfiram. Annu. Rev. Pharmacol. Toxicol. 21, 575-596.
15. 3H]-dopamine accumulation by synaptic vesicles purified from rat striatum: Thiocyanate ion. Brain Res. 516, 155-160.
16. Fisher, C. M. (1989). 'Catatonia' due to disulfiram toxicity. Arch. Neurol. 46, 798-804.
17. Fukumori, R., Minegishi, A., Satoh, T., Kitagawa, H., and Saizo, Y. (1980). Changes in the serotonin and 5-hydroxyindoleacetic acid contents in rat brain after ethanol and disulfiram treatments. Eur. J. Pharmacol. 61, 199-202.
18. Glowinski, J., Cheramy, A., Romo, R., and Barbeito, L. (1988). Presynaptic regulation of dopaminergic transmission in the striatum. Cell. Mol. Neurobiol. 8, 7-17.
19. Goldstein, M., and Nakajima, K. (1967). The effect of disulfiram on catecholamine levels in the brain. J. Pharmacol. Exp. Ther. 157, 96-102.
20. Haley, T. J. (1979). Disulfiram: A reappraisal of its toxicity and therapeutic applications. Drug Metab. Rev. 9, 319-335.
21. Hassler, R., Haug, P., Nitsch, C., Kim, J. S., and Palk, K. (1982). Effect of motor and premotor cortex ablation on concentrations of amino acids, monoamines, and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific cortico-striatal transmitter. J. Neurochem. 38, 1087-1098.
22. Henry, J.-P., and Scherman, D. (1989). Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesicles. Biochem. Pharmacol. 38, 2395-2404.
23. Hoogenraad, T. U. (1988). Dithiocarbamates and Parkinson's disease. Lancet 8588(1), 767.
24. Hotson, J., and Langston, J. (1976). Disulfiram-induced encephalopathy. Arch. Neurol. 33, 141-142.
25. Huang, R.-C., Peng, Y.-W., and Yau, K.-W. (1993). Zinc modulation of a transient potassium current and histochemical localization of the metal in neurons of the suprachiasmatic nucleus. Proc. Natl. Acad. Sci. USA 90, 11806-11810.
26. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci. Lett. 101, 214-217.
27. Imperato, A., Angelucci, L., Casolini, P., Zocchi, A., and Puglisi-Allegra, S. (1992). Repeated stressful experiences differently affect limbic dopamine release during and following stress. Brain Res. 577, 194-199.
28. 3H]dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: A comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. J. Pharmacol. Exp. Ther. 262, 356-364.
29. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: An in vivo chronocoulometric study. Brain Res. 513, 156-160.
30. Kirubakaran, V., Faiman, M. D., Liskow, B., and Mayfied, D. (1986). Plasma measurements of disulfiram and its metabolites in a case of severe disulfiram-ethanol reaction. Psychiatr. J. Univ. Ottawa 11, 166-168.
31. Laplane, D., Attal, N., Sauzon, B., De Billy, A., and Dubois, B. (1992). Lesions of the basal ganglia due to disulfiram neurotoxicity. J. Neurol. Neurosurg. Psychiatry 55, 925-929.
32. Lauriault, V. V. M., and O'Brien, P. J. (1991). Molecular mechanism for prevention of N-acetyl-p-benzoquinoneimine cytotoxicity by the permeable thiol drugs diethyldithiocarbamate and dithiothreitol. Mol. Pharmacol. 40, 125-134.
33. Liddon, S. C., and Satran, R. (1967). Disulfiram (Antabuse) psychosis. Am. J. Psychiatry 123, 1283-1289.
34. Mamatha, R. K., and Nagendra, S. N. (1994). Effect of disulfiram administration on glutamate uptake by synaptosomes in rat brain. Eur. J. Pharmacol. (ETPS) 292, 89-94.
35. Marchand, J. E., Hershman, K., Kumar, M. S. A., Thompson, M. L., and Kream, R. M. (1990). Disulfiram administration affects substance P-like immunoreactive and monoaminergic neural systems in rodent brain. J. Biol. Chem. 265, 264-273.
36. Masuda, Y., and Nakayama, N. (1982). Protective effect of diethyldithiocarbamate and carbon disulfide against liver injury induced by various hepatotoxic agents. Biochem. Pharmacol. 31, 2713-2725.
37. McPherson, G. A. (1994). RADLIG. A Collection of Programs for the Analysis of Radioligand Binding Experiments. Manual, pp. 157-163. Elsevier-Biosoft.
38. Mokri, B., Ohnisyi, A., and Dyck, P. J. (1981). Disulfiram neuropathy. Neurology 31, 730-735.
39. Molinengo, L., Oggero, L., Ghi, P., and Orsetti, M. (1991). Action of chronic disulfiram administration on memory decay and on central cholinergic and adrenergic systems. Brain Res. 551, 72-77.
40. Moore, K. E. (1969). Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice. Biochem. Pharmacol. 18, 1627-1634.
41. Nagendra, S. N., Shetty, K. T., Subhash, M. N., Udaya, H. B., and Pradhan, N. (1993). Effect of disulfiram administration on brain tryptophan, serotonin and peripheral tryptophan content. Neurochem. Int. 22, 31-36.
42. Nilsson, G. E., Tottmar, O., and Wahlstrom, G. (1987). Effects of aldehyde dehydrogenase inhibitors on hexobarbital sensitivity and monoamine metabolism in rat brain. Brain Res. 409, 265-274.
43. Nilsson, G. E., and Tottmar, O. (1989). Effects of disulfiram and coprine on rat brain tryptophan hydroxylation in vivo. Neurochem. Res. 14, 537-540.
44. 3H]dopamine from rat nucleus accumbens and striatal slices. Neurochem. Res. 13, 403-407.
45. Philippu, A. (1976). Transport in intraneuronal storage vesicles. In The Mechanism of Neuronal and Extraneuronal Transport of Catecholamines (D. M. Paton, Ed.), pp. 215-246, Raven Press, New York.
46. Rainey, J. M. (1977). Disulfiram toxicity and carbon disulfide poisoning. Am. J. Psychiatry 134, 371-378.
47. Richter, J. A., Bare, D. J., Yu, H., Ghetti, B., and Simon, J. R. (1995). Dopamine transporter-dependent and -independent endogenous dopamine release from Weaver mouse striatum in vitro. J. Neurochem. 64, 191-198.
48. Rodbard, D. (1984). Lessons from the computerization of radioimmunoassays: An introduction to basic principles of modeling. In Computers in Endocrinology (D. Rodbard and G. Forti, Eds.). Raven Press, New York.
49. Schlichter, D., Da Prada, M., and Pletscher, A. (1975). Interference of inhibitors of dopamine-β-hydroxylase with uptake of monoamines by chromaffin granular membranes. Eur. J. Pharmacol. 34, 223-227.
50. 3H]dopamine. Eur. J. Pharmacol. 167, 309-310.
51. B binding in rat brain. Brain Res. 30, 30-34.
52. 3H]-tyramine in the central nervous system. Br. J. Pharmacol. 89, 15-25.
53. Vaccari, A. (1993). The tyramine binding site in the central nervous system: An overview. Neurochem. Res. 18, 861-868.
54. Vaccari, A., Del Zompo, M., Melis, F., Gessa, G. L., and Rossetti, Z. L. (1991). Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine. Br. J. Pharmacol. 104, 573-574.
55. 3H]-dopamine release from rat striatal synaptosomes. Eur. J. Pharmacol. 199, 185-189.
56. Yokoyama, M., Koh, J., and Choi, D. W. (1986). Brief exposure to zinc is toxic to cortical neurons. Neurosci. Lett. 71, 351-355.
57. Zorzon, M., Mase, G., Biasutti, E., Vitrani, B., and Cazzato, G. (1995). Acute encephalopathy and polyneuropathy after disulfiram intoxication. Alcohol Alcoholism 30, 629-631.